LBA17 - ASCENT: A randomized phase III study of sacituzumab govitecan (SG) vs treatment of physicians choice (TPC) in patients (pts) with previously treated metastatic triple-negative breast cancer (mTNBC)
Sacituzumab Govitecan
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: LBA17 - ASCENT: A randomized phase III study of sacituzumab govitecan (SG) vs treatment of physicians choice (TPC) in patients (pts) with previously treated metastatic triple-negative breast cancer (mTNBC) ### Output: Sacituzumab Govitecan